These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 19096014

  • 21. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF, Zhu XJ, Peng G, Dai DQ.
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [Abstract] [Full Text] [Related]

  • 22. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
    David GL, Yegnasubramanian S, Kumar A, Marchi VL, De Marzo AM, Lin X, Nelson WG.
    Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
    [Abstract] [Full Text] [Related]

  • 23. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B, Chim CS, Zeng H, Leung SY, Yang Y, Tu SP, Lin MC, Wang J, He H, Jiang SH, Sun YW, Yu LF, Yuen ST, Kung HF, Wong BC.
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [Abstract] [Full Text] [Related]

  • 24. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers.
    Youssef EM, Chen XQ, Higuchi E, Kondo Y, Garcia-Manero G, Lotan R, Issa JP.
    Cancer Res; 2004 Apr 01; 64(7):2411-7. PubMed ID: 15059893
    [Abstract] [Full Text] [Related]

  • 25. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
    Yuan BZ, Durkin ME, Popescu NC.
    Cancer Genet Cytogenet; 2003 Jan 15; 140(2):113-7. PubMed ID: 12645648
    [Abstract] [Full Text] [Related]

  • 26. The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma.
    Natsume A, Wakabayashi T, Tsujimura K, Shimato S, Ito M, Kuzushima K, Kondo Y, Sekido Y, Kawatsura H, Narita Y, Yoshida J.
    Int J Cancer; 2008 Jun 01; 122(11):2542-53. PubMed ID: 18240144
    [Abstract] [Full Text] [Related]

  • 27. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines.
    Liu Y, Hong Y, Zhao Y, Ismail TM, Wong Y, Eu KW.
    Cancer Invest; 2008 Jul 01; 26(6):575-82. PubMed ID: 18584348
    [Abstract] [Full Text] [Related]

  • 28. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
    Meng CF, Dai DQ, Guo KJ.
    Ai Zheng; 2008 Dec 01; 27(12):1251-5. PubMed ID: 19079988
    [Abstract] [Full Text] [Related]

  • 29. Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers.
    Yun J, Song SH, Park J, Kim HP, Yoon YK, Lee KH, Han SW, Oh DY, Im SA, Bang YJ, Kim TY.
    Lab Invest; 2012 Jul 01; 92(7):1033-44. PubMed ID: 22508389
    [Abstract] [Full Text] [Related]

  • 30. Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells.
    Han H, Yang X, Pandiyan K, Liang G.
    PLoS One; 2013 Jul 01; 8(9):e75136. PubMed ID: 24040395
    [Abstract] [Full Text] [Related]

  • 31. DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML.
    Lund K, Cole JJ, VanderKraats ND, McBryan T, Pchelintsev NA, Clark W, Copland M, Edwards JR, Adams PD.
    Genome Biol; 2014 Aug 30; 15(8):406. PubMed ID: 25315154
    [Abstract] [Full Text] [Related]

  • 32. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
    Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE.
    Cancer Res; 2001 Oct 01; 61(19):7025-9. PubMed ID: 11585728
    [Abstract] [Full Text] [Related]

  • 33. Promoter CpG methylation in cancer cells contributes to the regulation of MUC4.
    Yamada N, Nishida Y, Tsutsumida H, Goto M, Higashi M, Nomoto M, Yonezawa S.
    Br J Cancer; 2009 Jan 27; 100(2):344-51. PubMed ID: 19127263
    [Abstract] [Full Text] [Related]

  • 34. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM, Valdespino-Castillo VE.
    Cir Cir; 2012 Jan 27; 80(5):470-80. PubMed ID: 23351455
    [Abstract] [Full Text] [Related]

  • 35. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
    Chan DW, Lee JM, Chan PC, Ng IO.
    Int J Cancer; 2008 Sep 01; 123(5):1043-52. PubMed ID: 18553387
    [Abstract] [Full Text] [Related]

  • 36. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
    Ando T, Nishimura M, Oka Y.
    Leukemia; 2000 Nov 01; 14(11):1915-20. PubMed ID: 11069027
    [Abstract] [Full Text] [Related]

  • 37. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
    Hudecek M, Bartsch K, Tschiedel S, Niederwieser D.
    Dtsch Med Wochenschr; 2008 Jul 01; 133(28-29):1511-6. PubMed ID: 18597211
    [Abstract] [Full Text] [Related]

  • 38. Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission.
    van der Torren CR, van Hensbergen Y, Luther S, Aghai Z, Rychnavská ZS, Slot M, Scherjon S, Kröger N, Ganser A, Weissinger EM, Goulmy E, Hambach L.
    PLoS One; 2015 Jul 01; 10(3):e0119595. PubMed ID: 25774796
    [Abstract] [Full Text] [Related]

  • 39. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA.
    Oncogene; 2001 Nov 22; 20(53):7787-96. PubMed ID: 11753657
    [Abstract] [Full Text] [Related]

  • 40. Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer.
    Smith HA, Cronk RJ, Lang JM, McNeel DG.
    Cancer Res; 2011 Nov 01; 71(21):6785-95. PubMed ID: 21880588
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.